Gene · 196528
Papers2,393
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,393
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mapping Mutations and Signaling Network Interactions to Guide Precision Therapy in Gallbladder Cancer. | Cancer Rep (Hoboken) | 2026 | 42817222 | PubTator, text mining | PubMed |
| Calcitriol alleviates ARID2-deficient gastric cancer metastasis via inhibition of the Wnt/β-catenin signaling pathway. | Transl Oncol | 2026 | 42771913 | PubTator, text mining | PubMed |
| ARID2 Loss Destabilizes PBAF and Drives Colorectal Cancer. | Mol Carcinog | 2026 | 42762512 | PubTator, text mining | PubMed |
| Fronto-central N200 lateralization during cue-dependent attentional orienting and response control in children with developmental dyscalculia. | Child Neuropsychol | 2026 | 42640197 | PubTator, text mining | PubMed |
| Genotypic and Phenotypic Profile of 50 Cases With Chromatin Remodeling Complexes-Related Neurological Disorders. | CNS Neurosci Ther | 2026 | 42528014 | PubTator, text mining | PubMed |
| The genomic landscape and treatment outcomes associated with CDKN2A/MTAP loss in patients with non-small cell lung cancer. | Clin Cancer Res | 2026 | 42507545 | PubTator, text mining | PubMed |
| The CpG island methylator phenotype defines an immune-cold and therapy-resistant subtype of cutaneous melanoma. | Front Immunol | 2026 | 42421952 | PubTator, text mining | PubMed |
| Fulminant extraneural metastases in MYC-amplified Group 3 medulloblastoma: a pediatric case report. | Childs Nerv Syst | 2026 | 42399488 | PubTator, text mining | PubMed |
| Comparative analysis of genomic profiles and clinical outcomes in cholangiocarcinoma and gallbladder cancer. | Sci Rep | 2026 | 42259884 | PubTator, text mining | PubMed |
| A guide to selecting high-performing antibodies for ARID2 (UniProt ID: Q68CP9) for use in western blot, immunoprecipitation, and immunofluorescence. | F1000Res | 2026 | 42232299 | PubTator, text mining | PubMed |
| Clinical and molecular features associated with the presence of brain metastases and survival in patients with advanced thyroid cancer. | Oncologist | 2026 | 42213058 | PubTator, text mining | PubMed |
| Geographic and genetic diversity in gallbladder cancer mutation profiles: insights from a worldwide exome analysis. | EBioMedicine | 2026 | 42167123 | PubTator, text mining | PubMed |
| Whole exome sequencing of lung cancer in Indian patients reveals driver genes and novel mutations with therapeutic potential. | Indian J Surg Oncol | 2026 | 42038570 | PubTator, text mining | PubMed |
| [Retracted] MicroRNA‑155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2. | Int J Oncol | 2026 | 42028735 | PubTator, text mining | PubMed |
Multiomics Analysis Identifies Chromosomal Instability-Associated Immune-Related Signatures in Hepatocellular Carcinoma by Integrating Weighted Gene Coexpression Network Analysis (WGCNA) and Machine Learning. | Hum Mutat | 2026 | 42016321 | PubTator, text mining | PubMed |
| SFK Inhibition Suppresses EBV-Encoded BART miRNAs and Induces Apoptosis in EBV-Positive Gastric Epithelial Cells. | Cancers (Basel) | 2026 | 41976305 | PubTator, text mining | PubMed |
| Screening of Hepatocellular Carcinoma in Hepatic Cirrhosis Patients by a Novel Blood-Based Multi-Omics Test. | Technol Cancer Res Treat | 2026 | 41869803 | PubTator, text mining | PubMed |
| Molecularly guided therapies for advanced primary liver cancers refractory to systemic treatment: Results from the 2025 French genomic medicine initiative. | J Hepatol | 2026 | 41865801 | PubTator, text mining | PubMed |
| EPB41L4A-AS1 long noncoding RNA acts in both cis- and trans-acting transcriptional regulation and controls nucleolar biology. | Elife | 2026 | 41805684 | PubTator, text mining | PubMed |
| Incidence of P200 pemphigoid: A nationwide study. | J Eur Acad Dermatol Venereol | 2026 | 41793217 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/196528/papers